AppleMed Research Group, LLC.
Miami, Florida 33155
2 studies enrolling now · 17 studies all time
What they study most
Acute Treatment of Migraine, COPD, Diabetes Mellitus, Type 2, Hypothyroidism, Immunocompromised, Knee Osteoarthritis, Migraine, Overactive Bladder, Pediatric Migraine, Rheumatoid Arthritis
Studies at this site
- An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets. — Recruiting now
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
- A Study to Evaluate Solrikitug in Participants With COPD (ZION) — Recruiting now
- Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications — Completed
- A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee — Completed
- Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens — Completed
- A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults — Stopped early
- A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
- A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES) — Completed
- Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
- Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis — Stopped early
- A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products — Completed
- Randomized Trial in Adult Participants With Acute Migraines — Completed
- An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). — Completed
- A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed